The results of this study, which examined the relationship between p16 positivity and the muscle-invasiveness of urinary bladder cancers, showed that 22 (88.0%) of the 25 NMIBC cases tested positive for p16. The gene discussed is CDKN2A; the disease is urinary bladder cancer.